Evidence map›Paper›PMID 37391647›Full record

ReviewMolecular neurobiology2023

Molecular and Structural Insight into Adenosine A

Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dipanjan KaratiDepartment of Pharmaceutical Technology, School of Pharmacy, Techno India University, Kolkata, 700091, India.
Swarupananda MukherjeeDepartment of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, 124 B.L. Saha Road, Kolkata, West Bengal, 700053, India.
Souvik RoyDepartment of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, 124 B.L. Saha Road, Kolkata, West Bengal, 700053, India. souvikroy35@gmail.com.ORCID http://orcid.org/0000-0003-2980-0362
Saha Institute of Nuclear Physics · INTechno India University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

All biological tissues and bodily fluids include the autacoid adenosine. The P1 class of purinergic receptors includes adenosine receptors. Four distinct G-protein-coupled receptors on the cellular membrane mediate the effects of adenosine, whose cytoplasmic content is regulated by producing/degrading enzymes and nucleoside transporters. A

Indexed as

AdenosineNeurodegenerative DiseasesHumansLigandsPurinergic P1 Receptor AntagonistsReceptor, Adenosine A2AReceptors, Purinergic P1AdenosineLigandsPurinergic P1 Receptor AntagonistsReceptor, Adenosine A2AReceptors, Purinergic P1Adenosine receptorsAlzheimer’s diseaseAmyotrophic lateral sclerosisDepressionMicrogliaParkinson’s disease

Identifiers

PMID37391647
OpenAlexW4382653952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.